Answer
No. These products are licensed for prevention, not treatment of established CMV disease. Breakthrough CMV requires prompt specialist assessment.
Sources for this answer
- PREVYMIS 240 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- PREVYMIS 240 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.